Register for Upcoming Webinar on DEC. 8 @ 11AM

China Green Pathways: Expedite your Market Entry in China

2025 China NMPA Bluebook is here:

Download Your Copy Today

white papers

Services

Get Updated

Receive Updates in Your Inbox

CMD Blog

NMPA Review Report Released for Inari Medical’s FlowTriever Retrieval/ Aspiration System

July 16, 2025

NMPA Draft Guideline Opens Door for Foreign Medical Device Makers to Use Overseas Labs for China Registration Self-Testing

July 8, 2025

NMPA Roundup July 2025

July 8, 2025

Have Questions?

What is Conditional Approval?

Related Services

China NMPA Product Registration

Clinical Evaluation Report (CER)

Resources

NMPA (CFDA) Regulations

NMPA (CFDA) Newsletters

Recorded Webinars

White Papers

Brochures

Recent Events

RAPS Webcast: 2023 NMPA (CFDA) Key Updates and Look Ahead on 2024

Medical Device Made-in-China Policy: A Comprehensive Review and Implementation

Related Posts

NMPA Review Report Released for Inari Medical’s FlowTriever Retrieval/ Aspiration System

The NMPA granted innovation approvals to Inari Medical’s FlowTriever Retrieval/

NMPA Draft Guideline Opens Door for Foreign Medical Device Makers to Use Overseas Labs for China Registration Self-Testing

NMPA published a draft document “Implementation Guideline for the Self-Testing

NMPA Roundup July 2025

Here’s the latest China NMPA regulatory and clinical affairs news

Bridging the Gap for Rare Diseases: The FDA’s Humanitarian Use Device Program and China’s Emerging Role (II)

What Devices Received HUD Designation As examples, the following devices,

Bridging the Gap for Rare Diseases: The FDA’s Humanitarian Use Device Program and China’s Emerging Role (I)

FDA’s Humanitarian Use Device (HUD) program offers a crucial lifeline

27 Class III IVD Reagents Exempted from Clinical Trial

NMPA published the “Clinical Trial Exempt Catalog for In Vitro